126 related articles for article (PubMed ID: 38479165)
1. Research progress on asialoglycoprotein receptor-targeted radiotracers designed for hepatic nuclear medicine imaging.
Hua Y; Yu C
Eur J Med Chem; 2024 Apr; 269():116278. PubMed ID: 38479165
[TBL] [Abstract][Full Text] [Related]
2. Radiosynthesis and biological evaluation of an fluorine-18 labeled galactose derivative [
Sun P; Zhu Y; Han Y; Hu K; Huang S; Wang M; Wu H; Tang G
Bioorg Med Chem Lett; 2020 Jun; 30(12):127187. PubMed ID: 32307237
[TBL] [Abstract][Full Text] [Related]
3. Asialoglycoprotein receptor mediated hepatocyte targeting - strategies and applications.
D'Souza AA; Devarajan PV
J Control Release; 2015 Apr; 203():126-39. PubMed ID: 25701309
[TBL] [Abstract][Full Text] [Related]
4. Radiosynthesis and biological evaluation of fluorine-18 labeled N-acetylgalactosamine derivative [
Sun P; Han Y; Zhu Y; Hu K; Huang S; Tan J; Wang M; Wu H; Tang G
Nucl Med Biol; 2020; 88-89():1-9. PubMed ID: 32580089
[TBL] [Abstract][Full Text] [Related]
5. Physiological roles of asialoglycoprotein receptors (ASGPRs) variants and recent advances in hepatic-targeted delivery of therapeutic molecules via ASGPRs.
Hu J; Liu J; Yang D; Lu M; Yin J
Protein Pept Lett; 2014; 21(10):1025-30. PubMed ID: 24975671
[TBL] [Abstract][Full Text] [Related]
6. Asialoglycoprotein Receptor-Mediated Gene Delivery to Hepatocytes Using Galactosylated Polymers.
Thapa B; Kumar P; Zeng H; Narain R
Biomacromolecules; 2015 Sep; 16(9):3008-20. PubMed ID: 26258607
[TBL] [Abstract][Full Text] [Related]
7. (18)F-FBHGal for asialoglycoprotein receptor imaging in a hepatic fibrosis mouse model.
Kao HW; Chen CL; Chang WY; Chen JT; Lin WJ; Liu RS; Wang HE
Bioorg Med Chem; 2013 Feb; 21(4):912-21. PubMed ID: 23321012
[TBL] [Abstract][Full Text] [Related]
8. Glycomimetic ligands for the human asialoglycoprotein receptor.
Mamidyala SK; Dutta S; Chrunyk BA; Préville C; Wang H; Withka JM; McColl A; Subashi TA; Hawrylik SJ; Griffor MC; Kim S; Pfefferkorn JA; Price DA; Menhaji-Klotz E; Mascitti V; Finn MG
J Am Chem Soc; 2012 Feb; 134(4):1978-81. PubMed ID: 22280495
[TBL] [Abstract][Full Text] [Related]
9. Targeted delivery of atorvastatin via asialoglycoprotein receptor (ASGPR).
Zhang Y; Zhang X; Zeng C; Li B; Zhang C; Li W; Hou X; Dong Y
Bioorg Med Chem; 2019 Jun; 27(11):2187-2191. PubMed ID: 31005367
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of GalNAc-siRNA Conjugate Activity in Pre-clinical Animal Models with Reduced Asialoglycoprotein Receptor Expression.
Willoughby JLS; Chan A; Sehgal A; Butler JS; Nair JK; Racie T; Shulga-Morskaya S; Nguyen T; Qian K; Yucius K; Charisse K; van Berkel TJC; Manoharan M; Rajeev KG; Maier MA; Jadhav V; Zimmermann TS
Mol Ther; 2018 Jan; 26(1):105-114. PubMed ID: 28988716
[TBL] [Abstract][Full Text] [Related]
11. Ligands of the asialoglycoprotein receptor for targeted gene delivery, part 1: Synthesis of and binding studies with biotinylated cluster glycosides containing N-acetylgalactosamine.
Westerlind U; Westman J; Törnquist E; Smith CI; Oscarson S; Lahmann M; Norberg T
Glycoconj J; 2004; 21(5):227-41. PubMed ID: 15486455
[TBL] [Abstract][Full Text] [Related]
12. Capacity limits of asialoglycoprotein receptor-mediated liver targeting.
Bon C; Hofer T; Bousquet-Mélou A; Davies MR; Krippendorff BF
MAbs; 2017; 9(8):1360-1369. PubMed ID: 28876162
[TBL] [Abstract][Full Text] [Related]
13. ASGPR-Mediated Uptake of Multivalent Glycoconjugates for Drug Delivery in Hepatocytes.
Monestier M; Charbonnier P; Gateau C; Cuillel M; Robert F; Lebrun C; Mintz E; Renaudet O; Delangle P
Chembiochem; 2016 Apr; 17(7):590-4. PubMed ID: 26781030
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric analysis of asialoglycoprotein receptor expression predicts hepatic functional reserve after hepatectomy.
Ke Z; Li J; Zhe J; Liang LB; Yan L; Yi M
J Coll Physicians Surg Pak; 2014 Nov; 24(11):820-4. PubMed ID: 25404440
[TBL] [Abstract][Full Text] [Related]
15. N-Acetylgalactosamine Block-co-Polycations Form Stable Polyplexes with Plasmids and Promote Liver-Targeted Delivery.
Dhande YK; Wagh BS; Hall BC; Sprouse D; Hackett PB; Reineke TM
Biomacromolecules; 2016 Mar; 17(3):830-40. PubMed ID: 26854615
[TBL] [Abstract][Full Text] [Related]
16. Determination of the upper size limit for uptake and processing of ligands by the asialoglycoprotein receptor on hepatocytes in vitro and in vivo.
Rensen PC; Sliedregt LA; Ferns M; Kieviet E; van Rossenberg SM; van Leeuwen SH; van Berkel TJ; Biessen EA
J Biol Chem; 2001 Oct; 276(40):37577-84. PubMed ID: 11479285
[TBL] [Abstract][Full Text] [Related]
17. A new splice variant of the major subunit of human asialoglycoprotein receptor encodes a secreted form in hepatocytes.
Liu J; Hu B; Yang Y; Ma Z; Yu Y; Liu S; Wang B; Zhao X; Lu M; Yang D
PLoS One; 2010 Sep; 5(9):e12934. PubMed ID: 20886072
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and Clinical Pharmacology Considerations of GalNAc
Wang Y; Yu RZ; Henry S; Geary RS
Expert Opin Drug Metab Toxicol; 2019 Jun; 15(6):475-485. PubMed ID: 31144994
[No Abstract] [Full Text] [Related]
19. Interaction of a Triantennary Quinoline Glycoconjugate with the Asialoglycoprotein Receptor.
Palit S; Banerjee S; Mahata T; Niyogi S; Das T; Sova Mandi C; Chakrabarti P; Dutta S
ChemMedChem; 2021 Jul; 16(14):2211-2216. PubMed ID: 33860988
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte-targeted nuclear imaging using 99mTc-galactosylated chitosan: conjugation, targeting, and biodistribution.
Kim EM; Jeong HJ; Park IK; Cho CS; Kim CG; Bom HS
J Nucl Med; 2005 Jan; 46(1):141-5. PubMed ID: 15632044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
